|
Status |
Public on May 28, 2011 |
Title |
MMTV-Neu N222+229 Tumor, TIC fraction |
Sample type |
RNA |
|
|
Source name |
Fraction of the tumor with highly purified Tumor Initiating Cells
|
Organism |
Mus musculus |
Characteristics |
tissue: primary mammary tumor strain: FvB genotype: MMTV-Neu tumor size: less than 1.0 cm diameter
|
Treatment protocol |
Cells from each tumor (with the exception of N222 and N229, which were combined in a 1:1 ratio to obtain enough cells for the experiment) were FACS sorted into TIC and non-TIC/CD24- fraction.
|
Growth protocol |
Five independent primary mammary tumors from MMTV-Neu model (N250, N261, N283, N222, N229) were harvested and tumor cells were dissociated mechanically into single cell suspension.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was purified from the 8 samples using PicoPure RNA Isolation Kit (Arcturus)
|
Label |
biotin
|
Label protocol |
Affymetrix Mouse Gene 1.0 st microarray experiment were performed by the Centre of Applied Genomics (HSC, Toronto)
|
|
|
Hybridization protocol |
Affymetrix Mouse Gene 1.0 st microarray experiment were performed by the Centre of Applied Genomics (HSC, Toronto)
|
Scan protocol |
Affymetrix Mouse Gene 1.0 st microarray experiment were performed by the Centre of Applied Genomics (HSC, Toronto)
|
Description |
Gene expression data from fraction of the tumor with highly purified Tumor Initiating Cells
|
Data processing |
Microarray Data were normalized using RMA method via Partek software and absolute expression values were obtained
|
|
|
Submission date |
May 27, 2011 |
Last update date |
May 28, 2011 |
Contact name |
Jeff Liu |
E-mail(s) |
jeff.liu@utoronto.ca
|
Phone |
416-340-4800
|
Organization name |
University Health Network
|
Department |
Princess Margaret Cancer Center
|
Lab |
Zadeh Lab
|
Street address |
101 College Street, RM 4-601
|
City |
Toronto |
State/province |
Ontario |
ZIP/Postal code |
M5G 1L7 |
Country |
Canada |
|
|
Platform ID |
GPL6246 |
Series (1) |
GSE29590 |
Expression data from highly purified MMTV-Neu Tumor Initiating Cells (TICs) and the non-TIC CD24- fraction |
|